相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations
Casey L. Swanson et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles
Moran Shapira et al.
FERTILITY AND STERILITY (2015)
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Timothy R. Rebbeck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
Usha Menon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas F. Easton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels
R. J. Santen
CLIMACTERIC (2015)
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
Arindam Paul et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program
Anna M. Chiarelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Amy P. M. Finch et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis
Tara M. Friebel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Efrat Gabai-Kapara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
Claudia Marchetti et al.
BMC WOMENS HEALTH (2014)
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
Kelly Metcalfe et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Marcia Irene Canto et al.
GUT (2013)
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kelly-Anne Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
Anouk Pijpe et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Extended Indications for Nipple-Sparing Mastectomy
Markus Niemeyer et al.
BREAST JOURNAL (2011)
Breast cancer after bilateral risk-reducing mastectomy
A-B Skytte et al.
CLINICAL GENETICS (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Anna Marie Mulligan et al.
BREAST CANCER RESEARCH (2011)
Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
Belinda E. Kiely et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Risk of breast cancer in male BRCA2 carriers
D. G. R. Evans et al.
JOURNAL OF MEDICAL GENETICS (2010)
Prophylactic mastectomy and the timing of breast reconstruction
M. Morrow et al.
BRITISH JOURNAL OF SURGERY (2009)
Risk reducing mastectomy: outcomes in 10 European centres
D. G. R. Evans et al.
JOURNAL OF MEDICAL GENETICS (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: Design and baseline characteristics: A Gynecologic oncology group study
Mark H. Greene et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Nipple-sparing mastectomy: Where are we now?
Alice P. Chung et al.
SURGICAL ONCOLOGY-OXFORD (2008)
Breast cancer risk among male BRCA1 and BRCA2 mutation carriers
Yu Chuan Tai et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: Long-term experiences at the rotterdam family cancer clinic
Bernadette A. M. Heemskerk-Gerritsen et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer
CK Kuhl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers:: The PROSE Study Group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination
E Warner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers
LC Hartmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers:: a case-control study
SA Narod et al.
LANCET (2000)
分享论文
